Two West Capital Advisors’s Indivior Pharmaceuticals INDV Stock Holding History

Two West Capital Advisors’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$411K	Hold	10,500	–	–	0.2%	70
2026 Q1	$359K	Hold	10,500	–	–	0.19%	75
2025 Q4	$377K	Hold	10,500	–	–	0.22%	65
2025 Q3	$264K	Hold	10,500	–	–	0.16%	83
2025 Q2	$180K	Hold	10,500	–	–	0.12%	89
2025 Q1	$95.7K	Hold	10,500	–	–	0.08%	78
2024 Q4	$131K	Hold	10,500	–	–	0.11%	70
2024 Q3	$102K	Hold	10,500	–	–	0.08%	68
2024 Q2	$169K	Buy	+10,500	New	+$190K	0.16%	65

Other funds holding INDV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two West Capital Advisors's INDV Position: Q2 2026 in Review

Two West Capital Advisors held its Indivior Pharmaceuticals (INDV) position steady in Q2 2026 at 10,500 shares worth $411K. The position accounts for 0.2% of the portfolio, ranked #70.

Two West Capital Advisors first reported a position in INDV in Q2 2024 and has held it in 9 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

Two West Capital Advisors held 10,500 shares of Indivior Pharmaceuticals worth $411K as of Q2 2026.
Two West Capital Advisors left its Indivior Pharmaceuticals share count unchanged in Q2 2026.
Indivior Pharmaceuticals made up 0.2% of Two West Capital Advisors's portfolio in Q2 2026, its #70 holding.
Two West Capital Advisors first reported a position in Indivior Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Two West Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.